Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden

Fig. 2

Forest plots. Univariable analysis of patients with being RCB-TILs-positive found that this contributed significantly to prolonging DFS in all patients (p < 0.001, hazard ratio = 0.181) (a), TNBC patients (p < 0.001, hazard ratio = 0.099) (b), HER2BC patients (p = 0.026, hazard ratio = 0.123) (c), and HRBC patients (p = 0.039, hazard ratio = 0.258) (d)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us